Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 2
2007 2
2008 3
2009 5
2010 2
2011 5
2012 3
2013 5
2014 5
2015 3
2016 3
2017 6
2018 7
2019 8
2020 1
2021 8
2022 9
2023 4
2024 5
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.
Perkovic V, Barratt J, Rovin B, Kashihara N, Maes B, Zhang H, Trimarchi H, Kollins D, Papachristofi O, Jacinto-Sanders S, Merkel T, Guerard N, Renfurm R, Hach T, Rizk DV; APPLAUSE-IgAN Investigators. Perkovic V, et al. N Engl J Med. 2025 Feb 6;392(6):531-543. doi: 10.1056/NEJMoa2410316. Epub 2024 Oct 25. N Engl J Med. 2025. PMID: 39453772 Clinical Trial.
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Wong E, Nester C, Cavero T, Karras A, Le Quintrec M, Lightstone L, Eisenberger U, Soler MJ, Kavanagh D, Daina E, Praga M, Medjeral-Thomas NR, Gäckler A, Garcia-Carro C, Biondani A, Chaperon F, Kulmatycki K, Milojevic J, Webb NJA, Nidamarthy PK, Junge G, Remuzzi G. Wong E, et al. Among authors: eisenberger u. Kidney Int Rep. 2023 Sep 22;8(12):2754-2764. doi: 10.1016/j.ekir.2023.09.017. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106570 Free PMC article.
Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy.
Nester CM, Eisenberger U, Karras A, le Quintrec M, Lightstone L, Praga M, Remuzzi G, Soler MJ, Liu J, Meier M, Tawfik R, Junge G, Biondani A, Trapani AJ, Webb NJA, Wong EKS. Nester CM, et al. Among authors: eisenberger u. Kidney Int Rep. 2024 Oct 28;10(2):432-446. doi: 10.1016/j.ekir.2024.10.023. eCollection 2025 Feb. Kidney Int Rep. 2024. PMID: 39990880 Free PMC article.
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study.
Kavanagh D, Bomback AS, Vivarelli M, Nester CM, Remuzzi G, Zhao MH, Wong EKS, Wang Y, Krishnan I, Schuhmann I, Trapani AJ, Webb NJA, Meier M, Israni RK, Smith RJH; APPEAR-C3G investigators. Kavanagh D, et al. Lancet. 2025 Oct 11;406(10512):1587-1598. doi: 10.1016/S0140-6736(25)01148-1. Epub 2025 Sep 25. Lancet. 2025. PMID: 41016405 Free article. Clinical Trial.
Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch Methods.
Ziemann M, Lindemann M, Hallensleben M, Altermann W, Althaus K, Budde K, Einecke G, Eisenberger U, Ender A, Feldkamp T, Grahammer F, Guthoff M, Holzmann-Littig C, Hugo C, Kauke T, Kemmner S, Koch M, Lachmann N, Marget M, Morath C, Nitschke M, Renders L, Scherer S, Stumpf J, Schwenger V, Sommer F, Spriewald B, Süsal C, Zecher D, Heinemann FM, Verboom M. Ziemann M, et al. Among authors: eisenberger u. Transplant Direct. 2024 Aug 8;10(9):e1680. doi: 10.1097/TXD.0000000000001680. eCollection 2024 Sep. Transplant Direct. 2024. PMID: 39131238 Free PMC article.
Norovirus Infections in Kidney Transplant Recipients.
Gäckler A, Struve C, Mülling N, Eisenberger U, Korth J, Babel N, Kribben A, Fiedler M, Witzke O, Rohn H. Gäckler A, et al. Among authors: eisenberger u. Transplantation. 2021 Dec 1;105(12):2655-2660. doi: 10.1097/TP.0000000000003708. Transplantation. 2021. PMID: 33660657
Transplanting HCV-Infected Kidneys into Uninfected Recipients.
Halleck F, Budde K, Duerr M, Staeck O, Hofmann J, Eisenberger U, Herzer K, Sterneck M, Gottlieb J, Schulz U. Halleck F, et al. Among authors: eisenberger u. N Engl J Med. 2017 Sep 14;377(11):1103-4. doi: 10.1056/NEJMc1709315. N Engl J Med. 2017. PMID: 28902583 No abstract available.
Worse cardiovascular and renal outcome in male SLE patients.
Mihailovic J, Ribi C, Chizzolini C, Trendelenburg M, Von Kempis J, Dahdal S, Huynh-Do U; Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS). Mihailovic J, et al. Sci Rep. 2023 Oct 30;13(1):18628. doi: 10.1038/s41598-023-45171-7. Sci Rep. 2023. PMID: 37903784 Free PMC article.
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.
Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. Pascual J, et al. Among authors: eisenberger u. Transplant Rev (Orlando). 2019 Oct;33(4):191-199. doi: 10.1016/j.trre.2019.07.001. Epub 2019 Jul 23. Transplant Rev (Orlando). 2019. PMID: 31377099 Review.
The Tacrolimus Concentration/Dose Ratio Does Not Predict Early Complications After Kidney Transplantation.
von Samson-Himmelstjerna FA, Messtorff ML, Kakavand N, Eisenberger U, Korth J, Lange U, Kolbrink B, Aldag L, Schulze Dieckhoff T, Feldkamp T, Kunzendorf U, Harth A, Schulte K. von Samson-Himmelstjerna FA, et al. Among authors: eisenberger u. Transpl Int. 2023 May 9;36:11027. doi: 10.3389/ti.2023.11027. eCollection 2023. Transpl Int. 2023. PMID: 37229240 Free PMC article.
80 results